About 400 reports

  • 4.1 GENOMICS MARKET: OVERVIEW
  • USE OF GENOMICS IN SPECIALIZED/PERSONALIZED MEDICINE

Genomics market is projected to grow at a CAGR of 10.2% The global genomics market is estimated to grow at a CAGR of 10.2% from 2017 to 2022, to reach USD 23.88 billion in 2022 from 14.71 billion in 2017. The key factors driving the growth of the overall genomics market include the growing demand for rise in research activities...

  • Genomics
  • United States
  • Market Size
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.

Genomics Market Size, Share & Trend Analysis Report By Application, By Technology, By Deliverables, By End Use And Segment Forecasts, 2018 - 2025 Chapter ## Executive Summary ##. ## Market Snapshot Chapter ## Research Methodology ##. ## Information Procurement ##. ## Information or Data A

  • Genomics
  • United States
  • Forecast
  • Market Size
  • Illumina
  • Americas - Year-over-year growth 2018-2022 (%)

Several genomic projects focus on the diversity in human genomics research.

  • Genomics
  • United States
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • 4.7 TAKARA BIO USA HOLDINGS AND RUBICON GENOMICS ANNOUNCE MERGER AGREEMENT
  • 3.5 DIAGNOSTIC TECHNOLOGY DEVELOPMENT

“In Vitro Diagnostic Testing Services reaches 12 billion tests per year. Genomic technology and China healthcare expansion driving global growth.....” Report Overview: A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially...

  • Biomarker
  • Genomics
  • Molecular Diagnostic
  • United States
  • Market Size
  • 4.7 TAKARA BIO USA HOLDINGS AND RUBICON GENOMICS ANNOUNCE MERGER AGREEMENT
  • 3.5 DIAGNOSTIC TECHNOLOGY DEVELOPMENT

“Medical Laboratory Testing Services reaches 12 billion tests per year. Genomic technology and China healthcare expansion driving global growth.....” Report Overview: A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics....

  • Biomarker
  • Genomics
  • Molecular Diagnostic
  • United States
  • Market Size
  • 4.7 TAKARA BIO USA HOLDINGS AND RUBICON GENOMICS ANNOUNCE MERGER AGREEMENT
  • 3.5 DIAGNOSTIC TECHNOLOGY DEVELOPMENT

“Clinical Diagnostic Testing Services reaches 12 billion tests per year. Genomic technology and China healthcare expansion driving global growth.....” Report Date: April 3, 2017 Report Overview: A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion...

  • Biomarker
  • Genomics
  • Molecular Diagnostic
  • United States
  • Market Size

Key players contributing in this market are BGI, Illumina, Inc, Pathway Genomics, Genesis Genetics, ##andMe, Inc, ARUP Laboratories, Color Genomics Inc., and Myriad Genetics, Inc.

  • Genetic
  • Genomics
  • United States
  • Demand
  • Market Size
  • GENOMICS
  • GLOBAL GENOMICS MARKET, BY REGION, 2015-2022 (USD BILLION)

The biomarker technologies market is projected to grow at a CAGR of 9.7%. The biomarker technologies market is expected to reach USD 74.51 billion in 2022 from USD 46.97 billion in 2017, at a CAGR of 9.7% during the forecast period The growth of this market is mainly driven by increasing healthcare expenditure and...

  • Genomics
  • United States
  • Market Size
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • GERMANY: GENOME EDITING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TOP-DOWN APPROACH

The genome editing/genome engineering market is projected to grow at a CAGR of 14.5%. The global genome editing market is expected to grow at a CAGR of 14.5% to reach to USD 6.28 billion by 2022. The key factors propelling the growth of this market are rising government funding and growth in the number of genomics projects, high prevalence...

  • Genomics
  • United States
  • Horizon Discovery
  • Integrated DNA Technologies, Inc.
  • Merck & Co., Inc.
  • GENOMICS COMPANIES
  • THE ARRIVAL OF GENOMICS IS MEDICINE'S TRANSISTOR MOMENT

Healthtech - Thematic Research Summary Global healthcare industry is worth $8 trillion. At over $10,000 per capita, US healthcare spending is 30% higher than the world’s second highest spender-Switzerland-and approximately 6.5 times higher than levels in China. Because of this higher spending, the...

  • Genomics
  • United States
  • Medtronic, Inc.
  • Microsoft Corporation
  • Qualcomm Incorporated
  • Illumina
  • Assessment

BGI Genomics: Overview BGI Genomics Strength BGI Genomics: Strength analysis Assessment Strength: ## Low; ## High The company entered the market by offering the NIFTY test in 2010.

  • Genetic
  • Genomics
  • United States
  • Forecast
  • Illumina, Inc.

Consequently, a growth in the number of such protein profiling studies is expected to directly fuel demand for genomic and proteomic labeling techniques through to 2024.

  • Biochip
  • Bioinformatic
  • Genomics
  • United States
  • Demand
  • EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2017)
  • 7.4 OTHER END USERS

The gene expression market is projected to grow at a CAGR of 8.8% during the forecast period. The global gene expression market is projected to reach USD 4.9 billion by 2023 from USD 3.2 billion in 2018 at a CAGR of 8.8%. Growth in the gene expression market can be attributed to factors such as the decreasing cost of sequencing,...

  • Genomics
  • United States
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.

List of Data Sources List of Tables ##.

  • Genomics
  • United States
  • Market Size

Genomics In Cancer Care Market Analysis Table of Content Chapter ##.

  • Cancer
  • Genomics
  • Pathology
  • United States
  • Demand
  • MARKET OVERVIEW
  • UPCOMING CONFERENCES & AWARENESS PROGRAMS ON LIQUID BIOPSY

(US) Genomic Health, Inc.

  • Genomics
  • United States
  • Market Size
  • Biocept, Inc.
  • Biodesix Inc.
  • MARKET CHALLENGES

You can easily book an appointment with one online.

  • Genomics
  • United States
  • Lonza Group Ltd
  • Merck & Co., Inc.
  • Thermo Fisher Scientific, Inc.
  • 11.5.1 COMPANY SNAPSHOT (2015): AGILENT TECHNOLOGIES, INC.
  • MARKET SHARE ANALYSIS (6/7)

THE DIAGNOSTICS AND GENOMICS SEGMENT OF THE COMPANY OFFERS DIAGNOSTICS AND GENOMICS SOLUTIONS FOR RESEARCH AND CLINICAL LABORATORIES.

  • Genomics
  • United States
  • Abbott Laboratories, Inc.
  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • 9.2 RISING INVESTMENT IN GENOMICS & PROTEOMICS RESEARCH
  • 7.6 GENETIC TESTING TEST VOLUME

By 2024, United States molecular diagnostics market is expected to cross US$ 9 billion. Main factors pouring the growth of molecular diagnostics market are increased incidence of infectious diseases and different types of cancer. On the other hand, advancement of new technologies in the field of medicine and research fuels the molecular diagnostics...

  • Genomics
  • United States
  • bioMerieux S.A.
  • Cepheid
  • Hologic, Inc.
  • GENOMIC HEALTH
  • ROSETTA GENOMICS

This report covers the market for liquid biopsy, including cfDNA, CTC and other technologies. The market data in this report is segmented by those technologies type of cancer tested and by purpose - testing, screening, drug monitoring. Companies are profiled and the top ten companies are ranked and their recent activities detailed. Companies...

  • Genomics
  • United States
  • Epigenomics AG
  • QIAGEN N.V.
  • Roche Group

REST OF WORLD PART D: ANNEXURE ##.

  • Genetically Modified Organism
  • Genomics
  • Synthetic Biology
  • United States
  • Market Shares
  • Illumina
  • Other prominent vendors

About DNA Sequencing DNA sequencing is the process of determining the precise order of the four nucleotides, namely, adenine, guanine, cytosine, and thymine, in a strand of DNA. Technavio’s analysts forecast the global DNA sequencing market to grow at a CAGR of 20.93% during the period 2018-2022. Covered...

  • Genomics
  • United States
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.

MARKET ##.

  • Genomics
  • Proteomics
  • United States
  • Company Sales
  • Market Size
  • 7.2 GENOMICS
  • GENOMIC RESEARCHES FUNDED BY THE EPIDEMIOLOGY AND GENOMICS RESEARCH

The sample preparation market is poised to reach USD 7,203.2 million by 2021 from USD 5,512.2 in 2016, growing at a CAGR of 5.5% during the forecast period of 2016 to 2021. Sample preparation involves conversion of samples into a format which can be directly placed in the analytical instruments for analysis. The conversion process ranges...

  • Genomics
  • United States
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • PerkinElmer, Inc.

MARKET ##.

  • Genetic
  • Genomics
  • United States
  • World
  • Demand
  • FORENSIC, RELATIONSHIP, AND ANCESTRY TESTING
  • Advances in Technology

Thermo Fisher Scientific develops the Axiom Genome-Wide Human Origins ## Array, which is a genotyping panel that has genomic markers from ## different modern human populations and archaic hominids.

  • Genomics
  • United States
  • F. Hoffmann-La Roche Ltd.
  • Myriad Genetics, Inc.
  • QIAGEN N.V.

MARKET ##.

  • Genomics
  • APAC
  • United States
  • Company Sales
  • Market Segment

Global Biochips Industry BIOCHIPS MCP-## A GLOBAL STRATEGIC BUSINESS REPORT CONTENTS ##.

  • Biochip
  • Genomics
  • United States
  • Company Sales
  • Market Segment

Mapping of human genome, coupled with continuous technological advancements in cytogenetic techniques, has enabled researchers to gain insight into the disease-causing mechanism at a genomic as well as cellular level.

  • Genomics
  • United States
  • Demand
  • Forecast
  • Market Size

Application segment is divided into diagnostics and treatment, research and consumables, gene sequencing, drug discovery, forensics medicines, gene expression, proteomics, pre and postnatal screening, toxicogenomics and genomics.

  • Biochip
  • Genomics
  • United States
  • Forecast
  • Market Size